Thursday, January 16, 2020 | 1:00-2:00 PM EST

During this webinar, life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel will provide a review of current legal and regulatory developments that have had an impact on the U.S. biosimilar industry. Topics to be discussed include:

  • 2019 biosimilar approvals, launches, and anticipated launches
  • Summary of FDA guidance in 2019
  • Updates regarding pending court cases and appellate decisions
  • 2019 IPR trends
  • What to look forward to in 2020!
Fish & Richardson, P.C. is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933). Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during their registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only.

Registration Information